BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2002
View Archived Issues
Dose-dependent improvement on rotigotine CDS in Parkinson's patients
Read More
Altocor filed for European marketing approval
Read More
Name change for inhalation technology company
Read More
Novel therapy to reduce or eliminate insulin dependence proves effective in NOD mice
Read More
Compounds with anticonvulsant activity prepared and tested at Arzneimittelwerk Dresden
Read More
Lead Androgenics compound blocks androgen receptor activation at an early step
Read More
CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo
Read More
All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant
Read More
Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC
Read More
Small-molecule GnRH antagonist with good oral bioavailability presented at AACR meeting
Read More
Takeda presents new orally active antitumor agent for HER2-positive cancers
Read More
CTLA4-Ig cleared to enter phase I/II trial in ITP
Read More
Phase III trial of Affinitac in combination with Gemzar/cisplatin in NSCLC
Read More
Aquavan completes phase I study, safely achieves loss of consciousness
Read More
Ampligen evaluated in two new HIV/AIDS trials
Read More
Patient enrollment completed in phase II trial of interferon omega in chronic hepatitis C
Read More
Tularik presents first-quarter 2002 results
Read More
Broad-spectrum antimicrobial agents described by Chiron
Read More
Oxazolidinones patented by Abbott for bacterial infections, etc.
Read More
Tricyclic protein farnesyltransferase inhibitors with antiproliferative activity
Read More
New Chiron compounds reportedly useful for angiogenesis-related conditions
Read More
Roche designs new p38 kinase inhibitors
Read More